Plants that fight cancer edited by: Spyridon E. Kintzios, Maria G. Barberaki and Evangelia A. Flampouri
Material type: TextPublication details: Boca Raton CRC Press 2019Edition: 2nd edDescription: 503pISBN:- 9781498726405
- 616.994061 KIN-S
Item type | Current library | Collection | Shelving location | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|---|
Books | BITS Pilani Hyderabad | 610 | General Stack (For lending) | 616.994061 KIN-S (Browse shelf(Opens below)) | Available | 42934 |
Browsing BITS Pilani Hyderabad shelves, Shelving location: General Stack (For lending), Collection: 610 Close shelf browser (Hides shelf browser)
616.994 SIO-M Target discovery and validation reviews and protocols (Volume 2) / | 616.994 STE-M Cancer therapies : | 616.994 WAR-C Beat cancer daily : 365 days of inspiration, encouragement, and action steps to survive and thrive / | 616.994061 KIN-S Plants that fight cancer edited by | 616.994061 KLA-M Angiogenesis biology and pathology | 616.99407 WEB-G Molecular mechanisms of cancer / | 616.994071 CRA-D Cancer virus : the story of Epstein-Barr virus / |
Plants that Fight Cancer, Second Edition, is a compilation that reviews cancer treatment and research-based information on the plant kingdom as the source of both known and novel chemical moieties and mixtures, many of them still under identification. This new edition follows the organization of the first book with a considerable expansion of content that more than doubles the volume of information.
Divided into four segments, the first part is dedicated to a review of our current knowledge of cancer, the different types and incidence, the molecular pathways of the disease, and the various treatment protocols, with an emphasis on chemotherapy. The second part is a brief journey in pharmacognosy, with detailed information about each of the fourteen different chemical groups of plant secondary metabolites, their use in cancer chemotherapy, and updated information on the biotechnological production of the most representative compounds in clinical practice. The third part of the book comprises six chapters dedicated to either plant chemotherapeutical approaches to specific cancer types (e.g. bladder, prostate) or specific groups of plant secondary metabolites with novel and promising properties for cancer treatment (e.g. naphthoquinones, lectins, phenanthridone alkaloids). The fourth part, containing investigative information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level, is with no doubt the most analytical.
This new edition contains chapters on cytotoxic phenanthridone alkaloid constituents of the Amaryllidaceae; naphthoquinone-contained anticancer terrestrial plants; polyphenols and cancer immunology; medicinal plant product-based fabrication nanoparticles (Au and Ag) and their anticancer effects; bladder and prostate cancer; and plant lectins in cancer treatment.
There are no comments on this title.